Pregnancy SmartSiteTM
DefinitionBullous pemphigoid is a skin disorder characterized by blisters. CausesBullous pemphigoid is an autoimmune disorder that occurs when the body's immune system attacks and destroys healthy body tissue by mistake. Specifically, the immune system attacks the proteins that attach the top layer of skin (epidermis) to the bottom layer of skin. This disorder usually occurs in older persons and is rare in young people. Symptoms come and go. The condition often goes away within 5 years. In some cases, the condition is triggered by a medicine. SymptomsMost people with this disorder have itchy skin that may be severe. In most cases, there are blisters, called bullae.
Exams and TestsYour health care provider will examine the skin and ask about the symptoms. They will review your list of medicines. Tests that may be done to help diagnose this condition include:
TreatmentAnti-inflammatory medicines called corticosteroids may be prescribed. They may be taken by mouth or applied to the skin. More powerful medicines may be used to help suppress the immune system if steroids do not work, or to allow lower steroid doses to be used. Antibiotics in the tetracycline family may be useful. Niacin (a B complex vitamin) is sometimes given along with tetracycline. Your provider may suggest self-care measures. These may include:
Outlook (Prognosis)Bullous pemphigoid usually responds well to treatment. The medicine can often be stopped after several years. The disease sometimes returns after treatment is stopped. Possible ComplicationsSkin infection is the most common complication. Complications resulting from treatment may also occur, especially from taking corticosteroids. When to Contact a Medical ProfessionalContact your provider if you have:
ReferencesBilgic A, Murrell DF. Bullous pemphigoid. In: Lebwohl MG, Heymann WR, Coulson IH, Murrell DF, eds. Treatment of Skin Disease: Comprehensive Therapeutic Strategies. 6th ed. Philadelphia, PA: Elsevier; 2022:chap 32. Dinulos JGH. Vesicular and bullous diseases. In: Dinulos JGH, ed. Habif's Clinical Dermatology. 7th ed. Philadelphia, PA: Elsevier; 2021:chap 16. | |
| |
Review Date: 5/31/2023 Reviewed By: Ramin Fathi, MD, FAAD, Director, Phoenix Surgical Dermatology Group, Phoenix, AZ. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team. The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language. © 1997- A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited. | |